Study of the Oral Factor D (FD) Inhibitor ALXN2050 in PNH Patients as Monotherapy
Clinical trial NCT04170023 · TERMINATED
Trial details
- NCT number
- NCT04170023
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-16
- Primary completion
- 2023-04-27
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.